News & Articles
Results per page
25
10 Articles Found | Selected Filters:
Industry NewsLife Sciences
Ares Genetics and BGI Group collaborate for Coronavirus testing
Collaboration aims to aid in the distribution of next-generation sequencing and PCR testing kits for 2019-nCoV
Product NewsClinical Diagnostics
Curetis launches Unyvero LRT Panel for BAL specimens in the U.S.
Panel includes atypical pathogens and is expected to substantially increase total addressable market for the Unyvero system in the U.S.
Industry NewsLife Sciences
Curetis receives U.S. FDA 510(k) clearance of Unyvero LRT for BAL specimens
Commercial U.S. launch of this novel diagnostic tool to diagnose lower respiratory tract infections is expected in the first quarter of 2020
Industry NewsLife Sciences
Curetis Group subsidiary Ares Genetics signs R&D and option agreement with leading global IVD corporation
R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdb
Industry NewsClinical Diagnostics
Curetis and AKO MED ink distribution agreement covering four countries in CEE region
AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro
Product NewsLife Sciences
Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
The Unyvero Platform allows rapid testing for a broad range of pathogens and antibiotic resistance markers associated with life-threatening infections in hospitalized patients
Industry NewsLife Sciences
Ares Genetics Initiates AI-Powered Infectious Disease Test Development
ARESupa test aims at broad detection of microbial infections employing next-generation sequencing and artificial intelligence
Industry NewsLife Sciences
Curetis and MGI Advance Strategic Partnership in NGS-based Molecular Microbiology
Curetis and MGI's collaboration will enable short-term commercialisation of NGS-based molecular microbiology.